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Abstract: DNA viruses, like poxviruses, possess a highly stable genome, suggesting that adaptation
of virus particles to specific cell types is not restricted to genomic changes. Cowpox viruses are
zoonotic poxviruses with an extraordinarily broad host range, demonstrating their adaptive potential
in vivo. To elucidate adaptation mechanisms of poxviruses, we isolated cowpox virus particles
from a rat and passaged them five times in a human and a rat cell line. Subsequently, we analyzed
the proteome and genome of the non-passaged virions and each passage. While the overall viral
genome sequence was stable during passaging, proteomics revealed multiple changes in the virion
composition. Interestingly, an increased viral fitness in human cells was observed in the presence
of increased immunomodulatory protein amounts. As the only minor variant with increasing
frequency during passaging was located in a viral RNA polymerase subunit and, moreover, most
minor variants were found in transcription-associated genes, protein amounts were presumably
regulated at transcription level. This study is the first comparative proteome analysis of virus
particles before and after cell culture propagation, revealing proteomic changes as a novel poxvirus
adaptation mechanism.
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1. Introduction
Cell culture propagation of viruses is a common prerequisite for investigating viral infection [1].
This is because only in rare cases the amount of virus particles isolated from a naturally occurring
sample is sufficiently large for further characterization studies. Already in the very early days of
studying viral infection in cell culture, an adaptation of the virus to the host cell was observed [2,3].
Numerous further reports can be found throughout the history of virus propagation in cell culture,
underlining the importance of a comprehensive understanding of viral adaptation mechanisms [4–7].
While RNA virus adaptation mostly takes place by selection of genomic variants generated by
erroneous replication, resulting in a less stable genome compared to DNA viruses [8], DNA virus
adaptation mechanisms remain largely elusive. Low mutation rates of DNA viruses mainly result
from the viral DNA-dependent polymerase 3′–5′ exonuclease activity, correcting for inaccurately
incorporated nucleotides [9]. Additionally, some viruses, like herpes- [10] and poxviruses [11], encode
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proteins involved in DNA repair mechanisms. Hence, it can be hypothesized that DNA viruses may
adapt via mechanisms other than de novo mutations and selection of genomic variants. Therefore, this
study aimed to elucidate novel DNA virus adaptation mechanisms in cell culture by a combined
proteomic/genomic approach, using poxviruses as a model.
As a member of the Poxviridae family, the genus Orthopoxvirus (OPV) comprises highly complex
DNA viruses. With about 10−8 substitutions per nucleotide per replication cycle, OPV mutation
rates are considered to be rather low [12]. Moreover, OPV encode at least four proteins involved in
DNA repair mechanisms [11,13–15]. Nevertheless, besides their genome stability, OPV members like
cowpox virus (CPXV) possess an exceptionally broad host range [16] and cause zoonotic infections [17],
illustrating their adaptive potential in vivo. The number of zoonotic CPXV infections in Europe is
increasing [18] and concerns have been raised recently about the emergence of variola virus-like
viruses from zoonotic OPV, like CPXV and monkeypox virus, by natural evolution. This demonstrates
the need for a comprehensive understanding of OPV adaptation [19] and encouraged us to choose
CPXV as a model DNA virus for our proteomics/genomics approach.
Since isolated virus particles are capable of crossing the species barrier, it is assumed that adaptive
changes can be identified in the virus particle itself. Copy number variation (CNV) has been suggested
as the mechanism underlying rapid OPV adaptation [20]. However, CNV has only been described
in cell culture applying high selective pressure [20–22]. But in naturally occurring OPV CNV has
not been shown yet, possibly because it is a transient event [21]. Other OPV adaptation mechanisms
include gene reduction [23] and recombination [24]. All these mechanisms describe changes in the
viral genome. Although virions consist mainly of proteins, global proteomic changes in virus particles
during cell culture passaging have not been analyzed to date.
We isolated CPXV mature virions from a rat crust and passaged them five times either in human
epithelial cells (HEp-2), which are commonly used for virus propagation, or rat fibroblast cells (Rat-2),
as rats represent a natural reservoir of CPXV. The appearance of the cytopathic effect (CPE) was
cell-type specific but did not change among passages in the same cell line. However, an increase
in virus yield was observed in the fifth passage in HEp-2 cells but not in Rat-2 cells. To elucidate
mechanisms underlying this viral fitness change, we purified CPXV mature virus particles from the
crust and each passage and analyzed the genome sequence by next-generation sequencing (NGS) and
the proteome composition by tandem mass spectrometry (LC-MS/MS). Results showed that CPXV
genomes were overall stable during passaging. In contrast, proteome analysis revealed numerous virus
proteins that changed in an adaptation-related manner during passaging. While 15 and eight viral
proteins changed during passaging in HEp-2 and Rat-2 cells, respectively, only a single viral protein
changed comparably in both cell lines. Strikingly, proteins that increased in amount in HEp-2-passaged
virions were mainly associated with viral immune evasion. These proteomic adaptations may explain
the increase in viral fitness observed in HEp-2 cells. In search of mechanisms underlying the proteomic
adaptation, we found a single minor variant increasing in frequency during passaging in both cell
lines. Interestingly, the highest frequency (11.4%) correlated with the observed increase in viral fitness.
The mutation was localized in the second largest subunit of the viral RNA polymerase A25R and led
to an amino acid change from Lys to Thr. Besides protein kinase R (PKR) antagonism [21,22], A25R
mutations are associated with transcript elongation in the literature [25–28]. Together with the fact
that most minor genomic variants were located in transcription-associated genes, this suggests that
proteomic virion changes are regulated on transcription level. Summarized, our results elucidate
proteomic changes as a novel poxvirus adaptation mechanism which may also apply to other large
nucleocytoplasmic DNA viruses.
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2. Materials and Methods
2.1. Virus Isolation from Rat Crust
CPXV particles were purified from a crust originating from a Wistar rat which was intradermally
infected with CPXV strain RatHei09/1 (NCBI GenBank: KC813504.1). Seven days post infection (p.i.)
the crust was excised, cut into small pieces and homogenized with 20–25 ceramic beads in 500 µL of
10 mM Tris pH 9.0 at 6.0 m/s for 6 × 20 s using a FastPrep® FP120 Homogenizer (MP Biomedicals,
Santa Ana, CA, USA). After 3 min of sonication, the beads were pelleted and the supernatant was
saved. The homogenized crust was washed twice with 500 µL of 10 mM Tris pH 9.0, saving the
supernatants of the wash steps. To maximize virus yield, the remaining pellet was vortexed thrice
in 500 µL of 10 mM Tris pH 9.0 for 30 s and washed again twice with 500 µL of 10 mM Tris pH 9.0.
All supernatants, including those from washing steps, were pooled and nuclei and cell debris were
pelleted at 5000× g and 4 ◦C for 5 min. The supernatant was sonicated for 1 min prior to mature virion
purification by sucrose gradient centrifugation as described below.
2.2. Mature Virion Purification
Purification of intracellular mature virions (IMV) was done by rate-zonal sucrose gradient
centrifugation [29] in sterile SW28 centrifuge tubes. For crude purification, the supernatant was
centrifuged through a 36% sucrose cushion at 32,900× g and 4 ◦C for 80 min and the virus pellet was
re-suspended in 1 mL of 10 mM Tris pH 9.0. The virus suspension was sonicated for 1 min, layered on
a 24–40% continuous sucrose gradient and centrifuged at 26,000× g and 4 ◦C for 50 min. The virus
band was collected and stored at 4 ◦C, while the pellet was re-suspended in 1 mL of 10 mM Tris pH 9.0,
sonicated for 1 min and centrifuged through a fresh 24–40% continuous sucrose gradient as described
before. The virus bands were pooled and concentrated at 32,900× g and 4 ◦C for 60 min. The pellet
was re-suspended in 1 mL of 10 mM Tris pH 9.0 and stored at −80 ◦C.
2.3. Serial Passaging
For the analysis of CPXV adaptation in cell culture, purified virus particles from the crust
were serially passaged in triplicate in HEp-2 (ATCC# CCL-23) and Rat-2 cells (ATCC# CRL-1764).
Both cell lines were maintained in DMEM supplemented with 2 mM L-Gln, 5% FCS and 1% Pen/Strep.
For infection of the first passage, 2 × 106 cells in 4 mL of medium were infected with purified CPXV
particles from the crust at an MOI of 0.1, assuming that the number of genome equivalents (GE) of
gradient purified virions determined by qPCR equals the number of plaque forming units (PFU).
Cells were incubated with daily CPE documentation for 4 days. Non-infected control cells served as a
reference for CPE documentation. For virus isolation, cells were scraped into medium and pelleted
at 1000× g and 4 ◦C for 5 min. The cell pellet was re-suspended in 1 mL of 10 mM Tris pH 9.0
and disrupted using glass beads. After pelleting of glass beads, viral DNA was extracted from the
supernatant and the amount of GE was determined by qPCR. The next passage was infected at an
MOI of 0.1, assuming a ratio of GE to PFU of 82:1 in HEp-2 and 17:1 in Rat-2 cells, as determined
previously (Table S1). The according virus amount was added to the medium of an 80–90% confluent
cell monolayer and incubated with daily CPE documentation for 4 days. The procedure of cell
disruption, GE determination and infection of fresh cells was repeated 4 times for a total of 5 passages.
Thereby, the number and size of cell culture flasks per replicate and passage was increased as follows:
1 × T25 cm2 (P1), 1 × T75 cm2 (P2), 5 × T175 cm2 (P3–5).
2.4. Plaque Assay and Determination of Genome Equivalents
The number of PFU and GE was determined by plaque assay and qPCR, respectively, as described
previously [30].
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2.5. Determination of the GE-to-PFU Ratio in the Supernatant
HEp-2 and Rat-2 cells in T25 cm2 cell culture flasks were infected in quadruplicate with CPXV
strain RatHei09/1 at an MOI of 0.1. Four days p.i. cells were disrupted using glass beads and vigorous
vortexing. Glass beads were pelleted and the supernatant was analyzed by plaque assay and qPCR.
2.6. Real-Time Cell Analysis
The xCELLigence RTCA (real-time cell analysis) system was used to compare the status of cells
infected with the non-passaged crust and the passaged virions. Initially, background measurement
was done with 50 µL of medium per well in a 96-well E-Plate. A total of 10,000 cells (HEp-2 or
Rat-2) per well in 100 µL of medium were added and the Cell Index (CI) was monitored every 15 min.
After overnight incubation, cells were infected with purified CPXV at an MOI of 0.1 in 50 µL of medium
and impedance measurement was continued for 150 h [31].
2.7. Next-Generation Sequencing (NGS)
Viral DNA was isolated from purified mature virions using the PureLink® Viral RNA/DNA
Mini Kit (Invitrogen, Karlsruhe, Germany) according to manufacturer’s instructions but without
carrier RNA. Libraries were prepared with the Nextera® XT DNA Library Preparation Kit (Illumina,
San Diego, CA, USA) according to the manufacturer’s instructions and sequenced using an Illumina
MiSeq machine. Genomic sequence files are available from the NCBI Sequence Read Archive under
the BioProject ID 399073.
2.8. NGS Data Analysis
Raw reads were de-multiplexed (CASAVA v1.8 from Illumina) and quality-trimmed (Trimmomatic
v0.33 [32], FastQC v0.11.5 [33]). Fastq-files were received from the Bioinformatics Service Unit of the
Robert Koch Institute. Separation of viral and host reads was done using RAMBO-K (Read Assignment
Method Based On K-mers) [34]. Viral reads were de novo assembled using SPAdes v3.6.2 [35] and Velvet
v1.2.09 [36]. Bowtie2 v2.2.6 [37] was used both for the confirmation of read separation by RAMBO-K
and for the verification of de novo assemblies. Annotations were transferred from the CPXV GRI-90
reference strain (NCBI GenBank: X94355.2). As consensus sequences of replicates matched, reads of
the triplicates per passage and cell line were summarized for further analysis. To identify genomic
changes during CPXV passaging, assembled genomes were analyzed for variants/SNPs using the
“find variations/SNPs” feature in Geneious v10.0.5 [38]. The minimum coverage was set to 100 with a
minimum variant frequency of 0.01. Maximum variant p-value was 10−6 and minimum strand-bias
p-value 10−5 when exceeding 65% bias. All consensus sequences containing variant annotations
(11 sequences) were aligned using MAFFT high speed multiple sequence alignment program v1.3.5
with default parameters. Variant annotations were exported and manually reviewed. In the analysis,
tandem repeats were defined as repetitive regions of at least one nucleotide with at least four repetitions.
Mutations resulting in amino acid changes were added as isoforms to the proteomic database.
2.9. Sample Preparation for LC-MS/MS
Purified virus particles were pelleted in 500 µL of 10 mM Tris pH 9.0 at 25,000× g and 4 ◦C
for 30 min. Virus pellets were lysed in 30 µL of lysis buffer (4% Sodium dodecyl sulfate (SDS),
10 mM Tris(2-carboxyethyl)phosphine (TCEP), 40 mM 2-Chloroacetamid (CAA) in 100 mM Tris pH 7.6)
by heating at 95 ◦C for 5 min. Lysates were sonicated for 1 min, clarified at 16,000× g for 5 min
and prepared for LC-MS/MS analysis using a modified Filter Aided Sample Preparation (FASP)
method [39]. Briefly, 30 µL of lysate (<200 µg of protein, determined as in [30]) were filled up with
200 µL of 8M Urea in 100 mM Tris pH 8.5 (UA) and loaded onto a Microcon Centrifugal Filter Unit
with 30 kDa molecular weight cut-off. SDS was removed by washing three times with 200 µL of UA.
Urea was replaced by washing three times with 50 mM ammonium bicarbonate (ABC) and digestion
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was performed overnight at 37 ◦C in a wet chamber with Trypsin/Lys-C Mix in 40 µL of ABC using
a protein: enzyme ratio of 25:1. Tryptic peptides were recovered by centrifugation and eluted twice
with 40 µL of ABC. Peptides were desalted using 200 µL of StageTips with two Empore™ SPE Disks
C18 [40], dried in a vacuum concentrator and stored at −80 ◦C until LC-MS/MS analysis.
2.10. LC-MS/MS Analysis
Single-run shotgun proteome analysis was performed using an EASY-nanoLC (Proxeon,
Odense, Denmark) coupled to a linear trap quadrupole (LTQ) Orbitrap Discovery mass spectrometer
using the parameters in Table S2. The sample order was shuffled during measurement to
avoid systematic errors. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRoteomics IDEntifications (PRIDE) [41] partner repository
with the dataset identifier PXD007567.
2.11. Proteomic Data Analysis
Quality control of proteomic data was routinely performed using the proteomics quality control
(PTXQC) pipeline [42]. Identification and label-free quantification (LFQ) was done in MaxQuant v1.5.2.8,
using the parameters in Table S3. Further bioinformatics analysis of protein and peptide identifications
was done in Perseus. LFQ values were filtered for reverse hits, contaminants and proteins only identified
by site. Log2 transformed protein intensities were separated in (i) crust + HEp-2 passages (18 samples)
and (ii) crust + Rat-2 passages (18 samples). Each group was analyzed identically as follows: Rows were
categorically annotated in crust (technical triplicates) and P1–P5 (biological triplicates each) and filtered
for at least three valid values in at least one group. As linear correlation between crust and passaged
virus was rather low (0.4–0.6 Pearson correlation), viral proteins were analyzed separately from host
proteins. Missing values were imputed from normal distribution with default values mimicking
low abundance measurements (width 0.3, down shift 1.8) and median column normalization was
performed to account for different sample loads. Principal component analysis was done prior to
z-score normalization. Significant differences of z-score normalized protein intensities were analyzed
using an analysis of variance (ANOVA) test with 5% permutation-based false discovery rate (FDR) and
250 randomizations. ANOVA significant protein intensities were averaged and courses were correlated
to hypothesized adaptation-specific reference profiles, which were generated using the reference profile
feature included in the Perseus profile plot analysis (Figure S1). Proteins with a distance ≤0.1 to the
reference profiles were defined as being adaptation specific. Identical viral proteins correlating with
the same reference profiles in HEp-2 and Rat-2-passaged cells were defined as comparable between
cell lines. Host proteins were analyzed analogously to viral proteins. The crust was excluded from
the analysis because of the low linear correlation compared to cell culture-passaged virus. LFQ values
were filtered additionally for rat proteins in HEp-2 samples and vice versa to remove host-unspecific
proteins. Rows were filtered for at least 12 valid values and an ANOVA test was performed applying 1%
permutation-based FDR with 2500 randomizations. Mean values of ANOVA significant proteins were
hierarchically clustered using Euclidean distance and 300 clusters. Protein clusters including proteins
increasing or decreasing during passaging were defined as adaptation-specific host proteins.
3. Results
3.1. Replication Gain during Passaging in Human Cells
CPXV IMV particles were isolated from a rat crust and serially passaged five times in triplicate in
HEp-2 and Rat-2 cells. To estimate changes in viral fitness during passaging, the CPE was documented
and the virus yield determined. A cell type-specific CPE was detectable in both cell lines in all passages.
While Rat-2 cells showed a CPE on the first day p.i., HEp-2 cells showed morphological changes on
the third day p.i. However, morphological changes remained the same during passaging in both cell
lines (Figure S2). Although HEp-2 and Rat-2 cells showed diverse CPE appearance, the total virus
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yield in both cell lines was comparable, except for the fifth passage showing higher virus yields in
HEp-2 cells. In contrast, virus yields in Rat-2 cells showed no significant differences during passaging.
This indicated a replication gain of CPXV in human cells but not in rat cells (Figure 1).
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detachment (Figure 2). These observations were confirmed on repetition of the experiment (Figure
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Figure 2. Real-time cell analysis of HEp-2 and Rat-2 cells infected with CPXV crust and passages
reveals no differences among passages but heterogeneities of the crust  ( ) HEp-2 and (b) Rat-2 cells 
were seeded in 96-well E-plates and cell adherence was measured over time. About 24 h after seeding, 
cells were infected with purified CPXV originating from a rat crust or from different passages (P1–
P5) at an MOI of  (arrow) Shown are mean values ± SD of biological triplicates of passages 
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Figure 1. Virus yield during CPXV crust passaging reveals a replication gain in human cells.
Viral genome equivalents (GE) of passaged CPXV crust were determined by qPCR after cell lysis.
Shown are mean values ± standard deviation (SD) of normalized virus yield. Statistics: One-way
analysis of variance and Bonferroni’s multiple comparisons test (* p ≤ 0.05).
3.2. Real-Time Cell Analysis Indicates Heterogeneities of the Crust Isolate
Infection kinetics of CPXV crust and passages were studied using RTCA which is based on
impedance measurement by electrodes embedded in the well bottom. The cell index (CI) represents
the background-corrected relative impedance and increases with increasing interaction of cells with
the well bottom and vice versa. Therefore, the CI depends on cell status parameters like cell number,
morphology and adhesion. Passaged CPXV were analyzed with the same cells they had been
propagated in previously, revealing an overall faster detachment of Rat-2 cells compared to HEp-2
cells. Passages showed comparable homogenous courses in both cell lines. In contrast, replicates of the
crust showed clearly heterogeneous courses which clustered in two distinct courses: one representing
the course of the virus passages and another showing significantly faster cell detachment (Figure 2).
These observations were confirmed on repetition of the experiment (Figure S3). Since purified virus
particles were used, toxic effects may be excluded. Instead, heterogeneous courses may indicate that
the crust contained a heterogeneous virus population.
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Figure 2. Real-time cell analysis of HEp-2 and Rat-2 cells infected with CPXV crust and passages
reveals no differences among passage but heterogeneities of t crust. (a) HEp-2 and (b) Rat-2 cells
were seeded in 96-well E plates and cell adherence was meas over time. About 24 h after seeding,
cells were infected with purified CPXV originating from a rat crust or fro different passages (P1–P5)
at an MOI of 0.1 (arrow). Shown are mean values ± SD of biological triplicates of passages measured
in technical quadruplicates (n = 12) or six technical replicates of the crust, which cluster in two different
courses (crust_I and II) with each n = 3. NTC: non-infected cells.
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3.3. Genome Analysis of CPXV Crust and Passages
In the following, samples are abbreviated according to cell line and passage, e.g., “RP1” for first
passage in Rat-2 cells. To elucidate possible genomic changes underlying an increased viral fitness in
HP5, and moreover to elucidate possible changes in virus particles occurring in the absence of CPE
and yield changes, we applied deep sequencing to the crust and each passage. We obtained mean
genome coverages of more than 2500 in passages and about 1300 in the crust (Table S4). De novo
assembled viral genomes had a length of >216,300 bp, except for RP1 with 209,458 bp. In comparison,
the genome size of the CPXV strain RatHei09/1 used is specified with 208,980 bp in the NCBI database
(GenBank: KC813504.1). All 206 unique coding sequences (CDS) in the GRI-90 reference strain could
be transferred to assembled genomes, except for RP1. Here sequence information of the terminal five
genes was missing. Note that the terminal five CPXV genes D1L–D5L are inverted versions of I1R–I5R
located in the inverted terminal repeat region.
De novo assembled viral genome sequences did not reveal any variation in copy number.
Assemblies were verified by alignment of reads to the genome sequence. In doing so, duplicated genes
showed a clearly higher coverage than genes with a single copy, as demonstrated by the terminal five
genes with known duplication (Figure S4). Coverage of these genes was consistently higher than the
mean coverage across the genome adding two standard deviations. However, no other gene with
comparable increased read depth was identified in any of the samples, indicating that CNV did not
occur during passaging of the CPXV crust isolate.
Variant Analysis Reveals Only Minor Variants during Passaging
Comparison of consensus sequences revealed six differences between crust and passages. All six
variants were insertions or deletions localized in repetitive sequences outside of CDS. Notably, HP5
and RP5 consensus sequences differed from the crust only by 2 and 4 nt, implying the overall genome
stability of CPXV during a 5-passage cell culture propagation. Nevertheless, variant analysis revealed
at least 23 minor variants with more than 1% frequency in each sample. Notably, about 72% of all
variants were localized in tandem repeats. Among a total of 78 different variants in HEp-2 and 89
in Rat-2 cells, 54 were identical in both cell lines, showing also reproducible variant frequencies.
But despite these correlations, mutations shared in both cell lines were for the most part not detected in
the same passage, indicating a common underlying mechanism, which may temporally differ between
cell lines (Figure S5).
Altogether 14 mutated CDS were identified, including 12 CDS with amino acid change (Table 1).
Surprisingly, half of these CDS were essential genes associated mostly with transcription. The term de
novo mutation is used in the following to describe variants appearing for the first time in a passage.
De novo mutations were identified in both cell lines in the A26L gene encoding the A-type inclusion
protein, the uncharacterized D6L gene and the E10R gene encoding an mRNA-de-capping protein
(Table 1). Additionally, A26L, E10R and the A25R gene encoding the RNA polymerase 133 kDa
polypeptide contained variants which were also detected in the crust, indicating pre-existing variants
rather than de novo mutations. Furthermore, a frequency accumulation of a single variant was
observed. This was an A→C transversion at position 269 in A25R leading to a K→T substitution
(Lys90Thr). While variant frequency of this mutation in the crust was 3.1%, HP5 displayed a frequency
of 11.4% and RP4 a frequency of 9.5%. The Lys90Thr in the A25R gene was the only CDS-localized
mutation detected in every sample and, moreover, the only mutation that increased in frequency
during passaging, indicating a selective advantage of this mutation.
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Table 1. Mutations in coding sequences during CPXV crust passaging.
CDS a Pos. b Nucleotide Change PE c Amino Acid Change
Variant Frequency HEp-2 Variant Frequency Rat-2
P0 P1 P2 P3 P4 P5 P1 P2 P3 P4 P5
A12R 728 A→G S K→R 1.2
A24R 1149 (A)8→(A)9 FS none 1.4
A25R 269 A→C S K→T 3.1 2.7 4.2 6.4 2.9 11.4 2.2 4.2 2.7 9.5 4.6
A25R 4 (A)8→(A)9 FS 1.3 1.4
A26L 1091 G→T S H→Q 1.1
A26L 1118 (GTT)8→(GTT)9 I P→QP 3.1 2.7 2.9 2.6 3.4 2.6 4.2 2.5
A26L 1115 (GTT)8→(GTT)7 D QP→P 4.6 4.3 3.8 3.8 4.2 4.6
A26L 1093 (TTG)8→(TTG)7 D Q→ 3.7 5.0 3.4
A26L 1093 (TTG)8→(TTG)9 I →Q 4.0 2.6 2.8
A9R 259 (A)8→(A)9 FS 1.5
C1L 465 C→A S R→S 1.2
C2L 168 C→T N none 1.5
D6L 613 ATA→TCC S Y→G 1.9
D6L 615 A→T T 1.0 1.1
D6L 616 +TCC I →G 8.8 7.4
D6L 611 C→T S S→N 8.7 7.4
D6L 606 G→A N none 8.5 7.1
E10R 474 (T)7→(T)8 FS 2.9 2.0 1.7 2.2
E10R 481 (T)7→(T)8 FS 2.6
E10R 716 A→T S E→V 1.8
H3R 28 A→G S N→D 1.3
J4L 101 +GG FS 1.1
J6R 319 A→G S K→E 2.1
L6L 1084 (T)10→(T)11 FS 1.9
O4R 1648 T→C S S→P 1.1
Variant frequencies are shown in %; P0: crust; a Coding sequence (CDS; gene name according to CPXV GRI-90);
b Position (Pos.) in gene; c Protein effect, S: Substitution, FS: Frame Shift, I: Insertion, D: Deletion, T: Truncation,
N: None.
As HP5 was the only sample showing a significant increase in virus yield, mutations that were
exclusively found in this passage may be relevant. Mutations limited to HP5 were identified in the
E10R gene, the uncharacterized C1L gene and the H3R gene, encoding a late transcription elongation
factor. However, variant frequencies were rather low (<1.8%).
3.4. Proteome Analysis of CPXV Crust and Passages
The proteome composition of non-passaged and passaged CPXV IMV particles was analyzed
by LC-MS/MS to elucidate possible proteomic changes. A total of 167 viral proteins and 3286 host
proteins (human, rat or contaminant) were identified. It should be noted that proteins outside of virions
may stick together with virion proteins and hence cannot be entirely removed during purification,
meaning that identified proteins may be incorporated in or associated with IMV particles.
3.4.1. Changes of Viral Proteins during Passaging
Mutations resulting in amino acid changes in viral proteins were included in the viral protein
database used for proteome analysis. Not surprisingly, as mutation frequencies were low (≤11.4%), no
isoforms were identified in proteome analysis.
A total of 167 highly confident CPXV proteins were identified. Proteins quantified in all triplicates
in at least one sample were considered for further analysis. Because linear correlation between crust
and cell culture passages was rather low, as demonstrated by a Pearson correlation of 0.4–0.6, host
proteins were removed from the analysis and analyzed separately, improving linear correlation of
virus proteins to >0.8 and even >0.9 between replicates (Figure S6). This indicated great differences
of host proteins in crust and passaged virus preparations, as expected for virus particles isolated
from diverse matrices like rat skin and cell culture monolayer. Surprisingly, principal component
analysisand hierarchical clustering of virus proteins revealed fairly good separability of CPXV particles
isolated from different passages (Figure 3). This suggested that the IMV proteome changed during cell
culture passaging, which is underlined by the heat map visualization in Figure 3 showing considerable
differences between crust and passages and also differences among passages.
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Figure 3. Principal compone t an lysis and hierarc ic l clustering of CPXV IMV proteins reveal
proteomic differences among passages. Normalized label-free quantification (LFQ) intensities of
virus proteins without missing values were used for (a) principal component analysis prior to z-score
normalization and (b) hierarchical clustering after z-score normalization.
Significance f differences was analyze by ANOVA a d daptati n-related viral proteins were
defined as pro eins displaying a cl ar abundance trend during pas aging or showing altered amounts
upon host change, meaning different amounts in crust and passages. To identify common adaptation
mechanisms, courses of viral proteins were compared between cell lines. This led to the identification
of the envelope protein G13 which changed comparably during passaging in both cell lines (Figure 4a).
Proteins with different courses in cell lines during passaging were considered to be cell line specific,
resulting in 15 viral proteins in HEp-2-passaged virions and eight viral proteins in Rat-2-passaged
virions (Figure 4b,c). The courses of these proteins revealed that the same number of viral proteins
changed upon infection of the first passage (six proteins per cell line; Figure 4b,c), while more viral
proteins changed during passaging in HEp-2 cells (nine proteins; Figure 4c) compared to Rat-2 cells
(two proteins; Figure 4b). Moreover, two proteins (A53 and Q1) changed in virions passaged in both
cell lines but showed different adaptation-associated courses (Figure 4b,c).
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Figure 4. Viral proteins changing in an adaptation-associated manner during passaging in HEp-2 and
Rat 2 cells. Proteins are sorted according to adaptation-associated time courses with distances ≤0.1
to reference profiles A–D, which are shown in Figure S1. (a) A single viral protein (G13) displays
comparable courses during passaging in both cell lines (cell line unspecific). Proteins changing in a
cell-line-independent manner were identified in (b) Rat-2- and (c) HEp-2-passaged virions. Shown are
normalized LFQ intensities (log2) of ANOVA-significant proteins. Error bars indicate means ± SD of
three biological replicates (passages 1–5) or three technical replicates (passage 0: crust).
Viral proteins that changed in a cell-type-specific manner had similar functions in both cell
lines, including proteins associated with viral membrane, immune evasion and DNA replication as
well as proteins with unknown function (Table 2). Membrane-associated proteins changed upon the
first passage in cell culture (E8 and E13 in HEp-2-passaged virions; B4 in Rat-2-passaged virions).
An exception was the membrane glycoprotein A34, which continuously increased in amount during
passaging in HEp-2 cells. Notably, all four immunomodulatory proteins (B17, C17, D1/I5 a d Q1) that
changed in HEp-2-passaged virions increased continuously in amount during passaging. In contrast, the
two immunomodulatory proteins (B7 and Q1) that showed altered protein amounts in Rat-2-passaged
virions changed upon the first passage but remained constant during further passaging (Figure 4 and
Table 2). Moreover, virions passaged in HEp-2 cells showed changes in viral proteins associated with
diverse other processes, including viral proteins with enzymatic activities (A48, G2 and H4).
Table 2. Function of viral proteins changing in a cell type-specific manner during passaging.
Protein Description a Function
HEp-2
A34 EEV glycoprotein me brane
E8 Cell-surface-binding protein me brane
E13 Scaffold protein me brane
B17 Soluble IFN-α/β receptor immune evasion
C17 Complement control protein immune evasion
D1/I5 Secreted chemokine-binding protein immune evasion
Q1 Inhibitor of TNF-R and TLR signaling immune evasion
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Table 2. Cont.
Protein Description a Function
HEp-2
C6 Uncharacterized protein unknown
C10 Uncharacterized protein unknown
F2 Uncharacterized protein unknown
G16 Uncharacterized protein unknown
A48 Cu-Zn superoxide dismutase-like protein others
G2 dUTPase others
H4 Glutaredoxin-2 others
A53 DNA ligase DNA replication
Rat-2
B4 EEV type-I membrane glycoprotein membrane
A50 Uncharacterized protein unknown
A52 Uncharacterized protein unknown
B3 Uncharacterized protein unknown
C14 Uncharacterized protein unknown
B7 IFN-γ receptor-like protein immune evasion
Q1 Inhibitor of TNF-R and TLR signaling immune evasion
A53 DNA ligase DNA replication
a According to UniProt; nomenclature CPXV GRI-90.
3.4.2. Changes of Host Proteins during Passaging
In contrast to the passaged samples, the crust host proteome was dominated by rat collagen-α 1
and 2, which is the predominant fibril-building collagen type of the skin. It was no surprise to identify
this protein in extraordinarily high amounts in a sample originating from rat skin. However, for the
analysis of changes in host protein abundance, the crust had to be excluded, because similarity to
the passaged virion host background was too low for comparison, as indicated by a poor Pearson
correlation (<0.5).
Except for P3 and P4 in Rat-2 cells, all passages could be separated by principal component
analysis, indicating differences in host cell protein abundance during passaging (Figure S7).
The ANOVA test revealed 122 human proteins significantly altered in HEp-2-passaged virions and
398 rat proteins in Rat-2-passaged virions. Mean values of ANOVA-significant proteins were analyzed
for adaptation-related courses using Perseus. Because the crust had to be excluded from the analysis,
host proteins with different amounts in the crust and in passages could not be identified. Although most
host proteins did not show any adaptation-related courses, host proteins with changing amounts
during passaging were identified (Figure S8). Because LC-MS/MS is a highly sensitive analytical
approach, it is clear that many contaminating proteins are identified, as demonstrated by 3453 identified
host proteins. To discriminate between contaminant and virion-associated host proteins, an enrichment
analysis may be done, comparing the amount of host proteins in virions to the host protein expression
in cells [30]. Although this was not feasible in the present study, because no reference values of HEp-2
and Rat-2 protein expression were available, most host proteins that changed during passaging in an
adaptation-related manner have been previously identified in highly pure OPV IMV preparations, as
indicated in Figure S8 [30]. Enrichment values of proteins previously characterized as virion associated
are used in this study to discriminate between virion-associated host proteins and contaminants [30].
Thereby, proteins with at least a two-fold enrichment in OPV IMV particles compared to the whole
cell were considered as virion associated, resulting in twelve and eight host proteins in HEp-2-
and Rat-2-passaged virions, respectively (Table 3). Only the translation initiation factor 3 subunit
B (eIF3B) changed in virions passaged in both cell lines, showing increasing abundance during
passaging. Interestingly, a protein associated with cytoplasmic DNA sensing (XRCC5) increased
and an apoptosis-associated protein (PDCD6) decreased in abundance in HEp-2-passaged virions.
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In contrast, in Rat-2-passaged virions a serin/threonine-protein phosphatase increased in abundance
(Ppp2r4), while another one (Ppp2r1a) decreased during passaging. Moreover, a regulatory subunit
of the proteasome (Psmc5) increased during passaging in Rat-2 cells, while the proteasome activator
complex subunit 4 (Psme4) decreased in abundance.




Enrichment during Passaging b
P1 P2 P3 P4 P5
HEp-2
PFN-1 Profilin-1 35.1 1.3 0.5 −0.1 −0.6 −1.1
PGK1 Phosphoglycerate kinase 1 12.9 1.2 0.6 0.2 −1.3 −0.6
ARF1 ADP-ribosylation factor 1 12.8 1.4 0.4 −0.1 −1.0 −0.7
PDCD6 Programmed cell death protein 6 7.2 1.3 0.6 −0.5 −0.9 −0.6
XRCC5 X-ray repair cross-complementing protein 5 6.6 −1.1 −0.6 −0.2 0.5 1.4
PRDX6 Peroxiredoxin-6 4.3 1.5 0.4 −0.1 −1.0 −0.8
ATIC Bifunctional purine biosynthesis protein 3.7 −1.2 0.1 −0.8 0.9 0.9
ACP1 Acid phosphatase 1 3.3 1.2 0.6 0.1 −1.1 −0.8
HSPA8 Heat shock cognate 71 kDa protein 2.4 1.0 0.5 0.6 −1.3 −0.7
CAD CAD protein 2.4 −1.8 0.3 0.4 0.4 0.7
EIF3B Eukaryotic translation initiation factor 3 subunit 2.1 −1.1 −0.8 0.2 0.3 1.4
MPG DNA-3-methyladenine glycosylase 2.0 1.2 0.5 0.0 −1.2 −0.6
Rat-2
Sqstm1 Sequestosome-1 8.3 0.5 1.2 0.0 −0.5 −1.2
Dstn Destrin 7.6 1.1 −0.2 0.5 0.0 −1.4
Itpa Inosine triphosphate pyrophosphatase 4.6 −1.4 −0.2 0.5 0.7 0.5
Phb2 Prohibitin-2 3.4 1.0 0.9 −0.6 −0.3 −1.0
Psmc5 26S protease regulatory subunit 8 3.4 −1.1 −0.8 0.4 0.7 0.9
Eif3b Eukaryotic translation initiation factor 3 subunit B 2.1 −0.9 −1.0 0.3 0.8 0.8
Dnajc7 DnaJ homolog subfamily C member 7 2.1 0.8 0.6 −0.1 0.3 −1.6
Rab6a Ras-related protein Rab-6A 2.0 0.5 1.2 −0.3 −0.3 −1.2
a iBAQ ratio OPV IMV to HepG2 ≥ 2 according to [30]; b Log2 (normalized LFQ); P1–P5: passage 1–5.
4. Discussion
Cell culture passaging is the gold standard for virus isolation and propagation [1]. Vaccinia virus
(VACV), the OPV member used as a vaccine in smallpox eradication, was the first virus grown
in vitro [43] and its adaptation to cell culture has already been observed in the 1960s, reporting initially
poor virus growth that improved during passaging [3,44]. At that time the observed adaptation was
thought to result from a selection of pre-existing genomic variants [44]. However, by now it is known
that this is only one possible adaptation mechanism of poxviruses. There are diverse studies verifying
the adaptive potential of poxviruses in cell culture on the genomic level. However, these studies
used already cell culture-adapted viruses like VACV [45], extreme cell culture passaging, e.g., more
than 500 passages for modified vaccinia virus Ankara (MVA) [46], or artificial selection pressure on
distinct genes by knockdown of complementary genes [20]. Therefore, prior to this study, it remained
elusive how poxvirus particles adapt to cell culture right after isolation from a natural host without
selective pressure by gene knockout. As for research purposes, commonly less than five passages
are sufficient to isolate and propagate OPV for further analyses, these first passages are of special
interest. It is known that extensive cell culture passaging leads to altered or even attenuated viruses,
like MVA [46], but changes of virus particles during early passages have been hardly investigated
prior to the present study.
In this study, modern omics-techniques were applied to analyze the adaptation of CPXV in cell
culture during the first five passages. Poxvirus adaptation in cell culture may be primarily observed
by differences in CPE or virus yield. These changes may be detected by standard methods, like plaque
assay or qPCR, which are generally performed during virus isolation in cell culture. In the present
study, CPXV particles were isolated from a rat crust and passaged five times in a human and a rat cell
line. Passaging resulted in reproducible viral fitness between cell lines during the first four passages.
However, an increase in viral fitness was observed in human cells in the fifth passage, indicating an
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adaptation of CPXV to human cells. As rat cells are closer related to the host organism from which
CPXV were isolated than human cells, a lesser degree of adaptation to these cells seems plausible.
Nevertheless, passaged viruses showed no differences in RTCA in both cell lines. As RTCA was based
on measurement of cell attachment to the surface, it seems conclusive that results are in agreement
with CPE observation which revealed no differences.
Genomic adaptation of CPXV may occur either by CNV [20], de novo mutations or selection
of pre-existing variants. In the present study CNV was not detected and the overall CPXV genome
stability during passaging in two different cell lines was shown. Although no structural variant became
dominant during passaging, deep sequencing allowed the identification of minor variants in each
passage. Strikingly, variants were primarily found in tandem repeats. These so-called microsatellites
can be found throughout the whole poxvirus genome, accounting for about 24% of the sequence [47].
Previously, early stop mutations were found to be accumulated in chordopoxvirus microsatellites,
leading to the hypothesis of microsatellite hypervariability as a major source of poxvirus genome
variability and hence as a source of poxvirus adaptation [47]. Our data suggests that hypervariability
in microsatellites is a CPXV adaptation mechanism in cell culture.
CDS-localized mutations were primarily found in transcription-related genes. This seems
conclusive, because poxviruses replicate in the cytoplasm of the host cell and therefore need to encode
their own transcription machinery which may adapt to the host. However, variant frequencies of
transcription-associated genes were rather low (≤3%), except for a single substitution in the A25R gene,
showing up to 11.4% variant frequency in virions passaged in human cells. This Lys90Thr substitution
in the RNA polymerase gene A25R was the only variant accumulating in frequency during passaging.
The OPV DNA-directed RNA polymerase is composed of eight subunits, which partially display
similarity to the eukaryotic polymerase [48,49]. Also the second largest subunit A25 displays homology
to the eukaryotic RNA polymerase [50]. Mutations in the A25R gene during OPV cell culture passaging
have already been described in the literature [21,22,25]. Most A25R mutations are associated with
isatin-β-thiosemicarbazone (IBT) resistance or reduced IBT sensitivity [22,25–27]. IBT treatment leads
to an abortive infection, presumably by increasing RNA processivity by either inhibiting transcription
termination or stimulating elongation, but the detailed mechanism is still unknown [22,28]. Cone [21]
and also Brennan and colleagues [22] observed A25R mutations in cell culture while applying selective
pressure to different PKR inhibitors. PKR is an IFN-stimulated gene and functions as antiviral sensor
protein of the host cell which detects viral dsRNA, leading to phosphorylation of the eukaryotic
translation initiation factor eIF2α, which in turn leads to translational shutdown. Established CPXV
PKR antagonists are encoded by the M3L and F3L genes [51,52]. It has been reported that passaging
of an F3L knockout mutant leads to gene expansion of M3L, which goes along with an adaptive
mutation in the A25R gene. Although this mutation reduced the dsRNA level, it also activated
PKR [21]. Furthermore, it has been shown that introduction of a rhesus cytomegalovirus-derived
PKR antagonist (rhtrs1) in an M3L/F3L double-knockout strain leads to either gene expansion of
rhtrs1 or to mutations in the A25R or A36R gene, both of which improving replication during cell
culture passaging [22]. Summarized, the literature data suggests that mutations in the A25R gene
are related to transcription elongation and PKR antagonism [28]. Hence, the accumulation of the
Lys90Thr variant during passaging of a CPXV crust isolate in two different cell lines may be related
to altered transcription, although the mutation site does not agree with mutations reported in the
literature [21,22,25,27]. Nevertheless, it can be stated that the second-largest subunit of the OPV RNA
polymerase is a major target of adaptive mutations. Furthermore, it may be speculated whether
the Lys90Thr variant observed at the highest frequency in the fifth passage in human cells may be
responsible for the significant increase in virus yield in this passage. One may argue that this mutation
was also observed in rat cell-passaged virions which did not show increased virus yield. But frequency
in rat cell-passaged virions was lower and effects may also be host dependent. Additionally, another
mutation in a gene associated with transcription elongation was identified exclusively in the fifth
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passage in human cells. This gene encodes the positive late transcription elongation factor H3 [53].
Therefore, the increase in virus yield may also be a combination of A25R and H3R mutations.
Apart from minor variants, CPXV genomes were remarkably stable during passaging, suggesting
adaptation on a different level. Hence, we analyzed global proteome changes of CPXV IMV particles
during passaging. Not only viral proteins that changed upon switch from the crust to the first passage
in cell culture but also changes in viral and host proteins during passaging were identified. For the
first time, this data proves that poxvirus adaptation takes place on virion proteome level. However, it
should be noted that the present study is descriptive and, from the observation of proteomic changes
in the presence of viral fitness changes, an association between both was hypothesized. Viral proteins
displaying adaptation-associated changes can be functionally categorized in proteins associated
with membrane, immune evasion and proteins with diverse enzymatic activities, as discussed in
the following.
OPV enter the host cell either by fusion with the plasma membrane or internalization by
endocytosis [54]. OPV entry has been shown to differ in a species- and strain-specific manner
and cell culture passaging has been suggested to contribute to the entry adaptation process [54–56].
During CPXV crust passaging in different cell lines, the abundance of the viral protein G13 changed in
a cell line-independent manner. G13 is the most abundant viral envelope component in extracellular
enveloped virion (EEV) particles and target of the anti-poxvirus drug ST-246 [57]. Although purified
IMV particles were analyzed and the co-purification of EEV particles seemed unlikely because of their
unstable outer membrane [58], it has been shown that EEV proteins can be detected even in highly
pure CPXV IMV preparations [30]. G13 plays a role in wrapping of IMV to produce EEV particles [57]
and G13-knockout mutants lead to severe attenuation in mice [59]. In cell culture, deletion of G13
has been shown to result in smaller plaque size [59]. However, the role of increased G13 amounts in
IMV particles passaged in HEp-2 and Rat-2 cells remains elusive. Furthermore, changes in A34 and
B4 protein amounts were detected during cell culture passaging in human and rat cells, respectively.
A34 in combination with A37 is required to repulse superinfecting virions. The A34/A37 complex
localizes on the surface of infected cells and induces actin tail formation upon contact with new virions
containing the B4 protein, leading to repulsion of virions to uninfected cells [60,61]. This mechanism
allows a four times faster virus spread than the replication cycle would permit. Moreover, an early
expression of A34 and A37 is required for effective virus spread and normal plaque formation in cell
culture [60]. Increased amounts of B4 and A34 in passaged virions may indicate an enhanced capacity
for repulsing virions from already infected cells. Incorporation of these proteins in virus particles
would enable a repulsion of virions right after infection, even before early viral protein expression.
This hypothesis may be underlined by the observation of an increased plaque size during passaging
(Figure S9). However, as an increase in plaque size was observed independently of the cell line, it may
be hypothesized that increased virus spread is a general mechanism underlying CPXV adaptation in
cell culture.
Poxviruses are remarkably complex viruses which encode diverse proteins to evade the host
immune system. Interestingly, all immunomodulatory proteins that increased in virions during
passaging (B17, C17, D1/I5 and Q1) are virulence factors in vivo [62–65]. B17 is a soluble IFN
receptor which possesses a remarkably broad capacity of binding and inhibiting type I IFN from
different species, e.g., human, rat, mouse, bovine and rabbit [66]. While VACV encoding B17 is
able to suppress IFN-α in mice, infection with a B17-deficient strain induces a type I interferon
antiviral response [67]. Replication of a VACV B17 knockout mutant is reduced in cell culture in
the presence of IFN, demonstrating that B17 is also advantageous for OPV replication in vitro [68].
Inflammation may be induced by the complement cascade or pro-inflammatory cytokines like CC
chemokines. C17 is a complement-binding protein, interfering with innate and adaptive immune
system components [65,69]. The D1/I5 protein is a chemokine-binding protein which is secreted
from infected cells to inhibit CC chemokine-mediated immune cell activation [70]. Q1 is the only
immunomodulatory protein that changed during passaging in both cell lines. While in Rat-2-passaged
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virions Q1 amounts increased upon the first passage, Q1 amounts were continuously increasing during
passaging in HEp-2 cells. The CPXV Q1 protein inhibits NF-κB and IRF-3 activation, although the
mechanism remains unclear [71,72]. Moreover, pro-inflammatory cytokine secretion from primary
monocytes is inhibited in the presence of Q1 [73]. However, the role of B17, C17, D1/I5 and Q1 in
cell culture remains to be elucidated. Nevertheless strikingly, amounts of these proteins continuously
increased in virions passaged in human cells. Hence, it may be hypothesized that changes in the
amount of immunomodulatory proteins, which are most abundant in the fifth passage, may underlie
the increased viral fitness observed in this passage in human cells.
Besides proteins of unknown function and viral proteins associated with membrane and immune
evasion, proteins associated with other enzymatic activities changed in cell culture-passaged virions,
including A48, A53, G2 and H4. The A48 protein encodes a protein with partial sequence homology to
the superoxide dismutase. But A48 does not show enzymatic superoxide dismutase activity, because
it lacks residues which are important for the according catalytic activity. As A48 influences neither
replication nor virulence [74], the role of this protein during poxvirus cell culture adaptation remains
elusive. The viral DNA ligase A53 increased in amount upon passaging in human cells and during
passaging in rat cells a continuous increase of A53 was observed. A53 recruits a host factor, the
cellular topoisomerase II, to viral replication sites during infection [75]. However, topoisomerase II
amounts did not change during passaging. The G2 protein is a dUTPase involved in DNA repair,
minimizing dUTP incorporation in viral DNA [76]. Upon passaging in human cells, G2 amounts
decreased in virions, coinciding with the fact that G2 deletion does not impact replication in vitro [76].
Finally, amounts of the oxidoreductase H4 increased continuously during passaging in HEp-2 cells.
Poxviruses encode their own disulfide bond formation machinery which is composed of the F10,
the A3 and the H4 protein. H4, also known as poxvirus glutaredoxin-2, is the last protein among
these three enzymes which act in a cascade-like manner [77]. H4 is known to catalyze the disulfide
bonds in viral membrane proteins and, moreover, is suspected to catalyze disulfide bonds in core
and lateral body proteins [78]. Poxviruses encode two glutaredoxin proteins, H4 and R2. While R2 is
non-essential for virus replication, H4 plays an essential role during virion assembly [79,80]. Hence, it
may be speculated whether increased amounts of H4 may be linked to enhanced viral fitness in the
fifth passage in HEp-2 cells. However, there is no literature available supporting this hypothesis.
Generally, changes in the amount of viral proteins during cell culture propagation may result from
either altered amounts of these proteins, higher incorporation rates in virus particles or a combination
of both. Altered protein amounts may be regulated on transcription or translation level or by protein
stability. Poxviruses encode their own transcription machinery [81]. As genomic changes were mainly
detected in transcription-related genes, it may be hypothesized that proteomic changes are regulated
on the transcription level.
The incorporation of host proteins in virions is a possible adaptation mechanism. VACV EEV
particles have been reported to incorporate host complement control proteins [45,82], cytoskeletal
proteins and chaperones [83]. Host protein expression is nearly shut down during poxvirus infection
by shutting down host mRNA expression [84]. Nevertheless, some host proteins remain constantly
expressed or even differentially regulated during infection, e.g., the mitochondrial proteins ND4
and COX-2 and heat shock protein HSP90 [85]. Additionally, host proteins are recruited to virus
factories during infection, e.g., topoisomerase II [75], ubiquitin [86] and the translation initiation
complex [85]. Moreover, transcription of poxvirus intermediate and late viral genes depends on
host factors. Host G3BP and p137 (CAPRIN-1) are involved in intermediate transcription [87], while
hnRNP A2/B1 [88] and RBM3 [89] are known to play a role in late viral promoter activation. All of
these factors, except for ND4 and COX-2, were identified in the present study. However, only
eIF3B changed in an adaptation-associated manner and was considered to be virionassociated [30].
Moreover, eIF3B is the only host protein that changed in both cell lines, showing increasing amounts
during passaging. It is the RNA-binding component of the eukaryotic translation initiation factor 3 and
part of the translation initiation complex, which is recruited to virus factories during OPV infection [85].
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Hence, it seems plausible that eIF3B may be incorporated in IMV particles during assembly but its
role for CPXV adaptation remains elusive. Apart from this single host protein changing during
passaging in both cell lines, eleven proteins changed exclusively in HEp-2-passaged virions and seven
in Rat-2-passaged virions.
Virion-incorporated cellular Profilin decreased during passaging in HEp-2 cells. Poxviruses encode a
viral Profilin protein A44 but in contrast to cellular Profilin, which modulates actin dynamics,
poxvirus Profilin rather influences polyphosphoinositides metabolism [90]. One may speculate
that viral Profilin amounts may increase, since cellular Profilin amounts decrease. However, this
was not the case. ARF1 amounts decreased during passaging in HEp-2 cells. ARF1 is involved
in the formation of Golgi-coated vesicles. During poxvirus infection, IMV particles are wrapped
with trans-Golgi membranes to form IEV particles but the role of ARF1 in poxvirus infection is
unknown [91]. Moreover, PDCD6 amounts decreased during passaging in HEp-2 cells. PDCD6 is
involved in endoplasmic reticulum-Golgi vesicular transport but has not been associated with a
role during poxvirus infection. XRCC5, also known as Ku80, is part of a large cellular DNA
repair complex which functions as pattern recognition receptor for DNA viruses, activating
innate immune response. Poxviruses encode a Ku80 antagonistic protein (D5L/I1R) which blocks
binding of the Ku80 complex to DNA [92]. Although it appears conclusive to identify Ku80 in
poxvirus mature virions, increased amounts during passaging in human cells cannot be explained.
Host proteins changing in Rat-2-passaged virions have not been directly linked to poxvirus infection.
However, interestingly, a regulatory subunit of the proteasome (Psmc5) increased in abundance
during passaging. Although multiple proteasomal subunits have been identified in highly pure OPV
preparations [30], the localization of the proteasome during poxvirus infection has not been analyzed
yet. For example, it has been reported that proteasomal subunits are recruited to replication centers
during cytomegalovirus infection [93].
Although multiple adaptation-related changes of virus and host proteins were identified during
passaging, general and technical limitations of the present study should be considered. We analyzed
the proteomic composition of virions and, in contrast to the viral genome, the proteomic stability
of OPV remains elusive. It has been stated in the most extensive OPV proteome study to date
that the virion proteome composition cannot be determined exactly by a fixed set of proteins [30].
Particularly, the relevance of the identified proteins and, moreover, the correlation of the virion
proteome and the phenotype are not known. Identified proteins may not get into the host cell or
the observed protein changes may be even too low to induce any phenotypic effect. Therefore, the
biological significance of identified proteins as well as the correlation between different virion protein
amounts and viral fitness have to be analyzed in more detail in the future. A technical limitation of the
applied shotgun proteome analysis is that the absence of a protein cannot be stated by the experimental
design. Peptides were analyzed in a data-dependent manner, meaning that the most intense peptides
are selected for fragmentation. This in turn means that peptides may be not identified because they are
absent, or because they are present at low abundance and hence not subjected to fragmentation.
The new insights given by the present descriptive study may be used for further investigations.
The detected changes of protein amounts associated with virions indicate a regulatory mechanism:
Either a mechanism for the selective protein incorporation in virions or a non-selective incorporation
as a result of a general regulation of protein amounts during infection. It is very interesting how OPV
accomplish this regulation. Our data suggests that transcriptional regulation plays a role in this context.
The effect of the Lys90Thr mutation in the viral RNA polymerase subunit A25R on transcription and
protein level seems particularly interesting for detailed analysis.
5. Conclusions
This study demonstrates that DNA virus particles change during passaging in cell culture, even
at a low number of passages. These changes may be detected by changes in viral fitness but they may
be also “silent”, meaning that virion changes do not result in viral fitness changes. We show that
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virion proteome changes may be associated with changes in viral fitness upon host switch, which was
simulated by a cell line species different from the natural host organism. In contrast, proteomic changes
without viral fitness changes were observed during passaging in a cell line originating from the host
species from which the virus was isolated. Our data reveal that proteomic adaptation presumably
contributes to virus adaptation to new hosts, allowing a more rapid adaptation of viruses with a stable
genome, namely DNA viruses. Finally, DNA virus adaptation in cell culture, in the absence of major
genomic variant changes and, moreover, in the absence of viral fitness changes, should be kept in mind
when working with cell culture-propagated DNA viruses, especially nucleocytoplasmic large DNA
viruses like poxviruses.
Supplementary Materials: Supplementary figures and tables are available online at www.mdpi.com/1999-4915/
9/11/337/s1.
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